Literature DB >> 1789968

Cytokines, fibrosis and the failure of glaucoma filtration surgery.

M C Gillies1, T Su.   

Abstract

Current therapies for the prevention of fibrosis after glaucoma filtering surgery can be effective but often produce unwanted side effects. An understanding of the cellular basis of the fibrotic reaction may lead to better treatments. Wound repair revolves around angiogenesis and the activation of fibroblasts by cytokines. These peptides, a number of which have been described, act together in intricately complicated networks to encourage fibroblast chemotaxis, proliferation and contractility, as well as to stimulate the production of glycosaminoglycans and collagen. Since interferons seem to inhibit many of these responses, they deserve further evaluation in the treatment of ocular fibrosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1789968     DOI: 10.1111/j.1442-9071.1991.tb00676.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  4 in total

1.  Local interferon alfa-2b for ocular cicatricial pemphigoid.

Authors:  M Gillies; I Francis; P McCluskey; D Wakefield
Journal:  Br J Ophthalmol       Date:  1996-10       Impact factor: 4.638

2.  A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).

Authors:  Mark Brian Sherwood
Journal:  Trans Am Ophthalmol Soc       Date:  2006

3.  Suppression of Human Tenon Fibroblast Cell Proliferation by Lentivirus-Mediated VEGF Small Hairpin RNA.

Authors:  Zhongqiu Li; Wen Hua; Xuedong Li; Wei Wang
Journal:  J Ophthalmol       Date:  2017-01-11       Impact factor: 1.909

4.  Epigenetic Modification Prevents Excessive Wound Healing and Scar Formation After Glaucoma Filtration Surgery.

Authors:  Ajay Sharma; Govindaraj Anumanthan; Marcos Reyes; Huiyi Chen; Jacob W Brubaker; Saad Siddiqui; Suneel Gupta; Frank G Rieger; Rajiv R Mohan
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-06-01       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.